TC Biopharm Holdings PLC
13F holders, Q1 2024 (March 31)5holders
$1.30avg. 13F price*
At the end of Q1 2024, 5 institutions reported holding TC Biopharm Holdings PLC in their 13F filings. The largest holders were Virtu Financial LLC ($23K), Csenge Advisory Group ($19K) and UBS Group AG ($384).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D400
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $43K |
| Exits | 3 | $244K |
Ownership 5 holders
| Virtu Financial LLC | 0.00% | New | 17,870 | $23K |
| Csenge Advisory Group | 0.00% | New | 14,500 | $19K |
| UBS Group AG | 0.00% | New | 293 | $384 |
| Headlands Technologies LLC | 0.00% | New | 98 | $128 |
| Wells Fargo & Company | 0.00% | No change | 50 | $66 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.